Clinical Trials
3 trialsNCT03618667 2023-05-12
GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
Samsung Medical Center
Phase 2 Completed
NCT04077255 2022-11-30
EGFR-targeted Therapy for Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT02352571 2016-07-06
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
GC Biopharma Corp
Phase 1 Unknown